Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy.
Spila Alegiani S, Crisafulli S, Giorgi Rossi P, Mancuso P, Salvarani C, Atzeni F, Gini R, Kirchmayer U, Belleudi V, Kurotschka PK, Leoni O, Ludergnani M, Ferroni E, Baracco S, Massari M, Trifirò G; ITA-COVID-19 Network.
Spila Alegiani S, et al. Among authors: crisafulli s.
Rheumatology (Oxford). 2021 Oct 9;60(SI):SI25-SI36. doi: 10.1093/rheumatology/keab348.
Rheumatology (Oxford). 2021.
PMID: 33856453
Free PMC article.